Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
World-First Nod For Yuhan's Lung Cancer Drug, In Korea
Eyes Now On J&J's Global Combo Trial
Jan 20 2021
•
By
Jung Won Shin
LECLAZA Becomes Korea’s 31st Approved New Drug • Source: Shutterstock
More from South Korea
More from Focus On Asia